EcoDrugPlus

Retinoic Acid Receptor Beta

Ensembl ID : ENSBGRG00000010314
Gene Symbol: RARB
1 Cross references
451 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSBGRG00000002743
Gene Symbol: RARG
1 Cross references
451 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSBGRG00000005191
Gene Symbol: RXRA
1 Cross references
249 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSBGRG00000019018
Gene Symbol: RXRB
1 Cross references
215 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSBGRG00000003237
Gene Symbol: RXRG
1 Cross references
277 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSBGRG00000016190
Gene Symbol: RPL10A
1 Cross references
222 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSBGRG00000021512
Gene Symbol: RPL14
1 Cross references
277 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSBGRG00000020732
Gene Symbol: RPL18
1 Cross references
276 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSBGRG00000026043
Gene Symbol: RPL18A
1 Cross references
198 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSBGRG00000013154
Gene Symbol: RPL19
1 Cross references
244 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSBGRG00000014229
Gene Symbol: RPL23
1 Cross references
217 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSBGRG00000003803
Gene Symbol: RPL24
1 Cross references
226 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).